Oregano Oil
Also sold as: Origanum vulgare oil · Oregano essential oil · Carvacrol-containing oregano oil
A concentrated essential oil containing carvacrol and thymol, marketed for intestinal microbes. Human evidence is sparse and often concerns multi-herb blends or isolated carvacrol rather than oregano oil.
Longevity
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Longevity: No human longevity benefit is established; this is an evidence gap, not a negative longevity RCT.
REALITY CHECK // An antibiotic-comparison paper has an equivalence-style title but its retrospective, multi-herb design cannot establish oregano equivalence to rifaximin. Candida claims largely extrapolate from laboratory studies, and an oregano-extract RCT in healthy nonsmoking men did not improve lipid peroxidation despite increased phenolic-acid excretion.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // No established EFSA/NIH UL is documented in this dossier. A small phase I carvacrol tolerability study is not a formal UL and cannot establish long-term oregano-oil safety.
Summary
There is no oregano-oil monotherapy RCT establishing SIBO treatment. A retrospective comparison of multi-herb regimens found breath-test normalization in 46% versus 34% with rifaximin, a nonsignificant difference that proves neither equivalence nor noninferiority. A 14-person parasite study was uncontrolled. Isolated-carvacrol respiratory findings cannot be transferred to commercial oil.
Mechanism
Carvacrol and thymol disrupt microbial membranes in laboratory experiments. Antifungal calcium/calcineurin effects and glucose-regulating pathways are preclinical; achievable, tolerable oral exposure and clinical efficacy are separate questions.
Typical studied dose
An uncontrolled study in 14 adults with intestinal parasites used 600 mg/day of emulsified oregano oil for 6 weeks. Multi-botanical SIBO courses lasted 4 weeks and do not define an oregano-only dose. No validated standalone SIBO dose or preparation-equivalent dose is supplied.
Upper limit
No established EFSA/NIH UL is documented in this dossier. A small phase I carvacrol tolerability study is not a formal UL and cannot establish long-term oregano-oil safety.
Popular stacks with Oregano Oil
Not enough stack data yet. A combination with Oregano Oil appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Enteric-coated oregano oil, label-declared 55% carvacrol Best for: Assessing an explicitly standardized bottle, not selecting a proven SIBO treatment. |
Unstandardized: active content unknown | no comparable trial range | Delayed intestinal release is a formulation rationale; comparative human efficacy is unestablished. May still worsen reflux despite coating. |
Caution [CAUTION // CHECK_PREPARATION] 55% is a marker declaration, not elemental content or a proven trial-equivalent dose. |
| Emulsified oregano oil, marker percentage unspecified Best for: Matching the preparation category of the small parasite report. |
Extract weight · marker not quantified | 600–600 mg | One uncontrolled human report used an emulsified product; release systems are not interchangeable. May irritate the GI tract; worsening symptoms do not prove microbial die-off. |
Caution [CAUTION // CHECK_PREPARATION] 600 mg compares whole oil preparation mass, not carvacrol. Marker percentage is unknown; it is not 100%. |
| Oregano oil drops in a carrier oil Best for: Label inspection of diluted products. |
Unstandardized: active content unknown | no comparable trial range | Concentration and drop mass vary by bottle; no verified drop-to-mg conversion is supplied. Undiluted concentrate can burn mucosa; carrier dilution does not prove safety. |
Caution [CAUTION // CHECK_PREPARATION] Do not treat drops, oil mg and carvacrol mg as interchangeable; variable marker concentration is unknown here. |
Common label traps
- TRAP_01 // As effective as antibiotics for SIBO
A nonsignificant result in a retrospective multi-herb comparison does not establish equivalence, noninferiority or efficacy of oregano alone. - TRAP_02 // Kills Candida in people
Laboratory anti-Candida activity is not a human treatment trial. Oral infection treatment must not be replaced on that basis. - TRAP_03 // Natural means gentle; worsening is die-off
Concentrated oil can irritate or injure mucosa. New reflux or pain may be an adverse effect, not a therapeutic milestone. - TRAP_04 // More carvacrol means more benefit
Marker concentration is not a validated clinical dose-response relationship.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- SIBO botanical combinations Anecdotal · benefit
A retrospective series of 104 patients reported 46% versus 34% breath-test normalization with multi-herb therapy versus rifaximin; not statistically different, and not an oregano monotherapy or valid equivalence trial. Adjunct RCT/open-label botanical reports remain combination-specific.
PMID 24891990 PMID 38613116 PMID 39339748 PMID 33074705 - Intestinal parasites Anecdotal · benefit
Uncontrolled open-label study, n=14, emulsified oil 600 mg/day for 6 weeks: Blastocystis disappeared in 8/11 cases and decreased in 3. No control or blinding; this cannot establish treatment efficacy.
PMID 10815019 - Asthma: isolated carvacrol Limited · benefit
Small single-center RCTs from one research group reported lung-function and inflammatory/oxidative-marker improvements in adults with asthma. They tested isolated carvacrol, not ordinary oregano oil, and need independent replication.
PMID 29193478 PMID 33773189 PMID 32249518 - Sulfur-mustard lung injury Limited · benefit
Small carvacrol RCTs reported pulmonary and biomarker improvements in chemically injured veterans. This unusually specific population does not support use in healthy readers.
PMID 30075886 PMID 29574804 PMID 30961947 - Candida: preclinical only No established evidence
Cell and formulation/animal experiments show antifungal activity; human clinical efficacy is unestablished, rather than disproved by a human RCT.
PMID 32426298 PMID 39067028 PMID 33468460 - Antibacterial mechanism No established evidence
Membrane disruption against microbes is mechanistic evidence. Safe oral clinical antimicrobial efficacy is not established by laboratory inhibitory concentrations.
PMID 27994215 PMID 19075694 - Glycemic control: preclinical only No established evidence
Reviews describe enzyme inhibition and rodent glycemic signals. No human glycemic RCT is supplied; this is not a diabetes treatment claim.
PMID 36098212 PMID 33966619 PMID 38019023 - Lipid peroxidation Limited · no benefit
An RCT in healthy nonsmoking men found greater phenolic-acid excretion but no short- or long-term effect on lipid peroxidation with oregano-fortified juice.
PMID 16881679
Reader questions
What dose treats SIBO?
No oregano-only SIBO dose is established here. Four-week multi-herb courses cannot be reduced to an oregano dose, and 600 mg/day came from a different, uncontrolled parasite study.
How do I distinguish die-off from harm?
No reliable home distinction is supplied. Reflux, nausea or abdominal pain can be irritation; stop and obtain assessment for severe or persistent symptoms rather than increasing the dose.
Is 90% carvacrol better than 55%?
A higher percentage describes composition, not proven superiority. Compare declared oil and marker amounts, dilution and tolerability; there is no validating human head-to-head trial here.
Stack interactions
- Caution Anticoagulants and antiplatelets [CAUTION // CLINICAL_REVIEW]
Possible bleeding effects are theoretical/preclinical; no human interaction study is supplied. Seek medication review and perioperative advice. - Caution Glucose-lowering drugs [CAUTION // CLINICAL_REVIEW]
Animal/mechanistic glucose-lowering signals justify caution, not a claim that oregano treats diabetes.
PMID 36098212 - Caution Berberine, allicin, neem and other antimicrobial herbs [CAUTION // CLINICAL_REVIEW]
Combining irritant products may worsen nausea and reflux. Clinical blend data do not identify which ingredient works.
Red flags: interactions and who should avoid it
Interactions
Anticoagulants, antiplatelets and planned surgery: bleeding concerns are theoretical/preclinical, not demonstrated human interactions. Diabetes drugs: possible additive glucose lowering is based on animal/mechanistic data. Other antimicrobial herbs may add GI irritation; rifaximin combinations need clinical oversight. Iron-absorption concerns are theoretical.
Avoid or ask a doctor first if
Avoid concentrated oil in pregnancy, breastfeeding and children because safety/dosing data are inadequate. Lamiaceae allergy may cross-react. Active reflux, gastritis or ulcers may worsen. Undiluted essential oil can injure oral/esophageal mucosa; do not ingest it neat. Stop for significant burning, persistent vomiting, severe abdominal pain or allergic symptoms; do not relabel these as proof of treatment success.
Sources (PubMed, 8)
- Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.
PMID 24891990 · 2014 · retrospective chart reviewRetrospective multi-herb SIBO comparison; 46% versus 34% breath-test normalization was not a demonstrated equivalence finding.
- Inhibition of enteric parasites by emulsified oil of oregano in vivo.
PMID 10815019 · 2000 · uncontrolled open-label clinical studyUncontrolled 600 mg/day emulsified-oil study for 6 weeks in 14 adults with parasites.
- Possible therapeutic effect of carvacrol on asthmatic patients: A randomized, double blind, placebo-controlled, Phase II clinical trial.
PMID 29193478 · 2018 · randomized controlled trialSmall phase II isolated-carvacrol asthma RCT; preparation and disease-specific.
- A double-blind, randomized, placebo-controlled clinical trial on the effect of carvacrol on serum cytokine levels and pulmonary function tests in sulfur mustard induced lung injury.
PMID 30075886 · 2019 · randomized controlled trialIsolated-carvacrol trial in sulfur-mustard lung injury, not general supplementation.
- Carvacrol Induces Candida albicans Apoptosis Associated With Ca2+/Calcineurin Pathway.
PMID 32426298 · 2020 · in vitro studyCandida apoptosis mechanism in vitro; no human treatment inference.
- Consumption of juice fortified with oregano extract markedly increases excretion of phenolic acids but lacks short- and long-term effects on lipid peroxidation in healthy nonsmoking men.
PMID 16881679 · 2006 · randomized controlled trialHuman oregano-extract RCT with null lipid-peroxidation findings despite phenolic exposure.
- Safety and tolerability of carvacrol in healthy subjects: a phase I clinical study.
PMID 30486682 · 2021 · phase I safety studySmall phase I carvacrol safety/tolerability evidence, not a formal UL.
- Oregano as a potential source of antidiabetic agents.
PMID 36098212 · 2022 · narrative reviewReview of potential antidiabetic mechanisms; no supplied human efficacy RCT.
Community comments
No approved comments yet. Comments are held for moderation.